PHM de Mulder

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

Cora N. Sternberg, PHM de Mulder, Jan H. Schornagel et al. · European Journal of Cancer · 2005 · 545 citations

Medicine, Oncology, Urology +9

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

Ivar Bleumer, Alexander Knuth, Egbert Oosterwijk et al. · British Journal of Cancer · 2004 · 173 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Medicine, Immunology, Oncology +14

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jan B. Vermorken, M. Clavel et al. · Annals of Oncology · 1994 · 136 citations

Medicine, Oncology, Chemotherapy +7

Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study

C. Seynaeve, Jan C. Schuller, K. Buser et al. · British Journal of Cancer · 1992 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16